| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Asia | | | | | 3.6 | 3.3 | 3.2 | 5.3 |
| Europe | | | | | | | | 7.8 |
| Virtual Care Infrastructure | 16.8 | 17.5 | 17.6 | 15.0 | 16.8 | 15.6 | 13.7 | 15.3 |
| Other | 21.0 | 24.7 | 22.9 | 23.7 | 23.3 | 17.0 | 16.9 | 16.8 |
| Total revenues | 37.8 | 42.1 | 40.5 | 38.7 | 43.7 | 36.0 | 33.9 | 45.2 |
| Revenue growth [+] | -13.4% | 17.2% | 19.4% | -14.4% | 37.0% | 180.7% | 528.3% | |
| Asia | | | | | -9.1% | 460.8% | | |
| Virtual Care Infrastructure | 0.1% | 11.7% | 28.0% | -2.0% | 141.5% | 2549.2% | | |
| Integrated Care Management | -29.9% | 48.3% | 53.7% | -68.0% | -30.6% | -58.5% | | |
| Cost of goods sold | 17.8 | 19.5 | 26.5 | 20.2 | 22.7 | 22.0 | 30.4 | 27.2 |
| Gross profit | 20.0 | 22.7 | 14.0 | 18.5 | 20.9 | 14.0 | 3.5 | 17.9 |
| Gross margin | 52.8% | 53.8% | 34.5% | 47.8% | 47.9% | 38.9% | 10.5% | 39.7% |
| Selling, general and administrative [+] | 15.2 | 15.6 | 11.5 | 18.7 | 16.4 | 14.9 | 34.8 | 14.5 |
| Sales and marketing | 2.4 | 4.6 | 5.0 | 4.8 | 3.5 | 3.4 | 5.0 | 3.1 |
| General and administrative | 12.8 | 11.0 | 6.5 | 13.9 | 12.9 | 11.5 | 29.8 | 11.5 |
| Research and development | 0.8 | 1.3 | 2.3 | 2.2 | 2.0 | 1.8 | 1.9 | 1.9 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 1.1 | 1.0 | 1.9 | 39.8 | 1.1 | 1.4 | 0.6 | 1.3 |
| EBITDA [+] | 4.2 | 5.6 | -0.1 | -41.0 | 2.8 | -2.7 | -32.2 | 1.9 |
| EBITDA growth | 48.6% | -302.9% | -99.8% | -2276.4% | 384.6% | -1414.8% | 15855.9% | -299.8% |
| EBITDA margin | 11.1% | 13.2% | -0.1% | -106.2% | 6.5% | -7.6% | -95.1% | 4.2% |
| Depreciation | 1.9 | 1.3 | 2.5 | 1.9 | 1.9 | 1.5 | 1.7 | 1.8 |
| EBITA | 2.3 | 4.3 | -2.5 | -42.9 | 0.9 | -4.3 | -33.9 | 0.0 |
| EBITA margin | 6.1% | 10.2% | -6.3% | -111.0% | 2.1% | -11.8% | -100.1% | 0.1% |
| Amortization of intangibles | 1.2 | 1.1 | 2.0 | 2.7 | 4.2 | 5.1 | 5.4 | 3.5 |
| EBIT [+] | 1.1 | 3.2 | -4.6 | -45.6 | -3.3 | -9.4 | -39.3 | -3.5 |
| EBIT growth | -134.8% | -133.8% | -88.3% | 1217.0% | 15.7% | 1211.8% | 7414.0% | 266.7% |
| EBIT margin | 3.0% | 7.5% | -11.3% | -117.9% | -7.5% | -26.0% | -115.9% | -7.7% |
| Non-recurring items [+] | 11.9 | 3.9 | 8.8 | 74.4 | 6.7 | 8.6 | 297.7 | 1.2 |
| Asset impairment | 8.2 | 0.5 | 1.8 | 106.1 | | 6.2 | | |
| Unusual expense | | | | -37.7 | | | | |
| Interest expense | 7.1 | 6.9 | 6.2 | 6.7 | 6.6 | 7.0 | 5.8 | 8.1 |
| Interest expense | 7.1 | 6.9 | 6.2 | 6.7 | 6.6 | 7.0 | 5.8 | 8.1 |
| Other income (expense), net [+] | 0.1 | 0.0 | 0.8 | -52.1 | 2.0 | 4.9 | 4.6 | 50.5 |
| Gain (loss) on debt retirement | | | | | | 0.1 | -0.8 | 0.9 |
| Unrealized gain/loss on derivatives | | 0.0 | 0.6 | 0.2 | | 4.8 | 4.0 | 49.9 |
| Change in fair value of warrants | | 0.0 | 0.1 | | | 0.1 | 0.1 | 0.4 |
| Pre-tax income | -17.8 | -7.6 | -18.8 | -178.8 | -14.7 | -20.0 | -338.1 | 37.7 |
| Income taxes | 0.9 | 0.0 | 8.4 | -13.2 | -2.2 | -2.3 | -2.1 | 6.7 |
| Tax rate | | 0.0% | | 7.4% | 15.2% | 11.5% | 0.6% | 17.8% |
| Minority interest | 0.5 | 0.4 | 0.2 | 0.2 | 0.0 | -0.3 | 0.0 | 0.2 |
| Net income | -19.1 | -8.1 | -27.4 | -165.8 | -12.4 | -17.4 | -336.0 | 30.8 |
| Net margin | -50.6% | -19.2% | -67.5% | -428.7% | -28.5% | -48.5% | -991.1% | 68.1% |
| |
| Basic EPS [+] | ($1.05) | ($0.51) | ($1.86) | ($11.17) | ($0.86) | ($1.21) | ($31.40) | $2.61 |
| Growth | 22.1% | -57.4% | -94.1% | -527.1% | 147.1% | 190.1% | 145867.5% | -25218.4% |
| Diluted EPS [+] | ($1.05) | ($0.51) | ($1.86) | ($11.17) | ($0.86) | ($1.21) | ($31.40) | $2.60 |
| Growth | 22.1% | -57.4% | -94.1% | -528.7% | 147.1% | 190.1% | 145867.5% | -25124.8% |
| |
| Shares outstanding (basic) [+] | 18.2 | 15.7 | 14.7 | 14.8 | 14.5 | 14.5 | 10.7 | 11.8 |
| Growth | 26.0% | 8.8% | 37.3% | 26.2% | -84.6% | 103.9% | -79.6% | -76.5% |
| Shares outstanding (diluted) [+] | 18.2 | 15.7 | 14.7 | 14.8 | 14.5 | 14.5 | 10.7 | 11.8 |
| Growth | 26.0% | 8.8% | 37.3% | 25.7% | -84.6% | 103.9% | -79.6% | -76.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |